SCHEMBL21390420

SCHEMBL21390420

CC1CN(C(=O)N2CCC3OCC(=O)N[C@@H]3C2)CCC1c1ccc(C(C)(F)F)cn1

nearest known ligand 0.51

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 10/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23148891 1.00 MGLL (0.51) MGLL
SCHEMBL23148883 1.00 MGLL (0.51) MGLL
SCHEMBL21390304 1.00 MGLL (0.51) MGLL
SCHEMBL23148935 1.00 MGLL (0.51) MGLL
SCHEMBL29616293 1.00 MGLL (0.51) MGLL
SCHEMBL23149192 0.90 MGLL (0.56) MGLL
SCHEMBL21390296 0.90 MGLL (0.56) MGLL
SCHEMBL23149194 0.90 MGLL (0.56) MGLL
SCHEMBL23211966 0.82 MGLL (0.61) MGLL
SCHEMBL23211965 0.82 MGLL (0.61) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3768684-B1 OXAZINE MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS HOFFMANN LA ROCHE (CH) 2023-02-22 EP disclosed
WO-2019180185-A1 OXAZINE MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2019-09-26 WO disclosed